Predict your next investment

HEALTHCARE | Medical Devices & Equipment / Patient Monitoring
elektron-eye-technology.com

See what CB Insights has to offer

Stage

Acquired | Acquired

About Elektron Eye Technology

Elektron Eye Technology is a subsidiary of Elektron Technology and home to a spectrum of fast-moving engineered product (FMEP) brands, including the Henson Perimeters and the Macular Pigment Screener (MPS II). They are the ophthalmic instruments of choice for eye care professionals involved in the screening and monitoring of glaucoma and age-related macular degeneration (AMD).On July 17th, 2020, Elektron Eye Technology was acquired y Topcon Healthcare Solutions. The terms of the transaction were not disclosed.

Elektron Eye Technology Headquarter Location

Broers Building JJ Thomson Avenue

Cambridge, England, CB3 0FA,

United Kingdom

+44 1223 371 000

Latest Elektron Eye Technology News

Topcon Healthcare acquires Henson perimeter business of Elektron Eye Technology

Jul 19, 2020

Topcon Healthcare acquires Henson perimeter business of Elektron Eye Technology Topcon Healthcare, a US ophthalmic device manufacturer, has acquired the Henson perimeter business of UK-based Elektron Eye Technology (EET) for an undisclosed price. The range of perimetry products acquired includes the Henson 9000 and Henson 7000 perimetry screening devices along with the transfer of a number of Elektron Eye Technology employees to the US company. Topcon Healthcare said that the manufacturing of the Henson perimetry screening devices will continue in the UK. According to the US ophthalmic device manufacturer, the Henson perimetry products are well known in the eye care sector for their accuracy, speed, and ease of use. Photo courtesy of Topcon Healthcare Solutions. Topcon Healthcare said that the Henson 9000 is the ideal perimetry screening device for the early detection of glaucoma and the ongoing monitoring of established loss. On the other hand, the Henson 7000 perimetry screening device is a lightweight, mobile perimeter designed for undertaking suprathreshold glaucoma screening in the central visual field. John Trefethen – Global VP of Marketing and Product Design for Topcon Healthcare said: “The acquisition of the Henson range of products will provide us with the opportunity to strategically develop this area of the company’s product portfolio. With Topcon’s growing emphasis on screening and early disease detection, the Henson product range perfectly complements our global strategy.” Related posts

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.